The RISE Above Smoking trial explores the impact of remote and in-person treatment settings on participants' ability to attend study sessions and adhere to treatment and study protocols. Participants are recruited based on their desire to quit smoking and are provided an 8-week course of dual nicotine replacement therapy while meeting with study staff for a total of 6 sessions in a 4-month period. The trial's experimental core is the 2-stage randomization process. Eligible participants are first randomized to attend either a remote or in-person intake session and then randomized again at intake to determine whether their remaining 5 sessions will take place remotely or in-person. The resultant 4-cell design allows for a balanced and rigorous assessment of the differences between participant accrual, retention, treatment adherence, and biospecimen collection in remote versus in-person settings.

Clinicaltrials.gov ID: NCT06822049

Current IRB Protocol

Consent Form

Protocol Paper: Under Review

Have a webinar you want to promote?

Use our contact form to reach us

Showing All Data Collection Instruments

Delve Deeper